Arnulf Stenzl, MD

Arnulf Stenzl, MD

Eberhard Karls University of Tuebingen Medical School

Tuebingen, Germany

Arnulf Stenzl, MD, is Deputy Spokesperson of RTG 2543 and the  Principle Investigator of Subproject C1 at the University of Stuttgart and a Professor and Medical Director in the Department of Urology at the University Hospital Tubingen in Germany. Dr. Stenzl has made significant contributions to the field of urology, with over 800 publications and scientific papers in peer-reviewed journals. His research and focus include prostate cancer, bladder tumors, and lymph node dissection.

Dr. Stenzl earned his medical degree and completed training in Urology at the Karl-Franzens University in Graz, Austria. Throughout his career, Prof. Dr. Stenzl has held numerous prestigious positions and worked at renowned medical institutions, including the University Hospital Graz, Inselspital in Switzerland, and the University Clinic Innsbruck.

Dr. Stenzl holds two international patents, is an investigator in numerous clinical trials, and has organized numerous national and international symposiums on uro-oncology. He has served as the Chairman of the Scientific Congress Office of the European Association of Urology (EAU), as Adjunct Secretary Science of the EAU, and currently serves as its Secretary General. Dr. Stenzl is a Board member of the European Cancer Organisation and was president of the German Association of Urology in 2020 and 2021. He is also a member of the editorial boards of several journals.

Talks by Arnulf Stenzl, MD

Advanced Prostate Cancer: Sequencing of Treatment

Advanced Prostate Cancer: Sequencing of Treatment

| Jun 2024

Arnulf Stenzl, MD, discusses the challenges of appropriately sequencing advanced prostate cancer treatment and presents possible solutions. In his presentation, he addresses:

Recent and Anticipated Changes in Advanced Prostate Cancer Treatment
The Issue of Physician Information Overload
The Lack of Easily Accessible Comparative Data Between Agents
Possible Applications of Artificial Intelligence in Literature Searches

Read More
Future Prospects of AI Technology in the Lower Urinary Tract

Future Prospects of AI Technology in the Lower Urinary Tract

| Aug 2023

Arnulf Stenzl, MD, discusses the future prospects of artificial intelligence (AI) combined with precision surgery and robotics in the diagnosis and treatment of the lower urinary tract. He outlines an intraoperative multisensory approach for tissue differentiation involving sensor development with mechanical, optical, and electric properties. Combined with AI modeling, the result is a scoring system for intraoperative identification of tissue characteristics based on multimodal/multiscale data with tissue differentiation by optical emission spectroscopy.

Dr. Stenzl displays data on the discrimination of tissue based on electrical impedance. He points out the value of discrimination of deeper tissue layers using model-based optical sensors to see and avoid, for example, vessels and nerves. Dr. Stenzl then describes a device for intraoperative real-time elastography, even at the cellular level.

He emphasizes the importance of consistent AI tissue modeling, covering multiple physical domains to combine different sensors and inform the best actions. Dr. Stenzl explains that AI can extract and reproduce features for navigation during surgery. Dr. Stenzl re-emphasizes the importance of precision surgery moving toward intraoperative diagnostics that builds on the traditional standard of frozen section and predicts the further development of precision surgery and AI technologies in the coming years.

Read More